SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Tejnaksh Healthcare informs about updates

21 Feb 2023 Evaluate

Tejnaksh Healthcare has informed that, its Managing Director, Ashish Rawandale has received Best Innovation Prize for inventing the Visual aid for catheterisation for female patients in USI conference 2023. This Innovation will help some women who cannot pass urine & have to catheterise themselves to empty their bladder. Female cannot see their urethra an hence difficult to self-catheterise. The Visual Aid for Catheterisation is a portable, affordable, wireless & mobile based enables patient to view their urethra on screen and catheterise herself.

The above information is a part of company’s filings submitted to BSE.


Tejnaksh Healthcare Share Price

15.06 0.04 (0.27%)
17-Apr-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×